Brazil – ANVISA discloses results of analysis on supplements

THE National Health Surveillance Agency (ANVISA in Portuguese) analyzed 41 creatine dietary supplements available in the Brazilian market. The products involve a total of 29 manufacturing companies. The evaluation was conducted in order to verify the regularity of these products in three specific aspects:

Creatine content;
Adequacy of labeling.
Presence of foreign matter.

For the analysis, a survey was carried out of the creatines most sold in the Brazilian market, in packages of 300 grams, which is the most common in the market. The sample collection was carried out in the second semester of 2024, in supplement manufacturing companies. Only in the state of Rio de Janeiro were samples collected by the State Health Surveillance (Visa) in the retail market. The other participating states were São Paulo, Santa Catarina, Paraná and Espírito Santo, following the market concentration in these states.

Brazil: Anvisa banned the marketing and advertising of the dietary supplements Lipotramine and Lipozepine, illegally sold as weight loss products

The National Health Surveillance Agency (ANVISA in Portuguese) banned the marketing, distribution, manufacture and advertising of the dietary supplements Lipotramine and Lipozepine, illegally sold as weight loss products, mainly on the internet, and determined their withdrawal. The measure was published by Resolution (RE) No. 2,167, dated June 30, 2022. The products are manufactured by Guki Nutracêutica Ltda. (CNPJ: 06789363000134).

Foods may not bear therapeutic claims

Anvisa has not approved weight loss claims for food supplements. Thus, any advertising that conveys such claims is irregular.